Golden State Equity Partners cut its holdings in The Sherwin-Williams Company (NYSE:SHW – Free Report) by 12.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,329 shares of the specialty chemicals company’s stock after selling 325 shares during the period. Golden State Equity Partners’ holdings in Sherwin-Williams were worth $889,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of SHW. GHP Investment Advisors Inc. increased its holdings in shares of Sherwin-Williams by 47.5% during the 3rd quarter. GHP Investment Advisors Inc. now owns 87 shares of the specialty chemicals company’s stock valued at $33,000 after acquiring an additional 28 shares during the last quarter. HHM Wealth Advisors LLC grew its holdings in Sherwin-Williams by 102.3% during the second quarter. HHM Wealth Advisors LLC now owns 89 shares of the specialty chemicals company’s stock valued at $27,000 after purchasing an additional 45 shares during the last quarter. Semmax Financial Advisors Inc. boosted its holdings in shares of Sherwin-Williams by 136.4% during the 2nd quarter. Semmax Financial Advisors Inc. now owns 104 shares of the specialty chemicals company’s stock worth $31,000 after buying an additional 60 shares during the period. VitalStone Financial LLC grew its stake in Sherwin-Williams by 233.3% in the 2nd quarter. VitalStone Financial LLC now owns 110 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 77 shares during the last quarter. Finally, Anfield Capital Management LLC acquired a new position in Sherwin-Williams during the 2nd quarter worth $38,000. 77.67% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Sherwin-Williams
In other news, CFO Allen J. Mistysyn sold 14,520 shares of Sherwin-Williams stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the completion of the transaction, the chief financial officer now directly owns 63,520 shares in the company, valued at approximately $23,301,041.60. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.60% of the company’s stock.
Sherwin-Williams Stock Up 0.7 %
Sherwin-Williams (NYSE:SHW – Get Free Report) last issued its quarterly earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 earnings per share for the quarter, missing the consensus estimate of $3.56 by ($0.19). Sherwin-Williams had a return on equity of 74.45% and a net margin of 11.09%. The business had revenue of $6.16 billion for the quarter, compared to the consensus estimate of $6.20 billion. During the same period in the prior year, the business earned $3.20 earnings per share. Sherwin-Williams’s revenue was up .7% compared to the same quarter last year. As a group, research analysts forecast that The Sherwin-Williams Company will post 11.32 EPS for the current fiscal year.
Sherwin-Williams Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 15th will be issued a dividend of $0.715 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $2.86 dividend on an annualized basis and a yield of 0.79%. Sherwin-Williams’s payout ratio is 30.49%.
Wall Street Analyst Weigh In
Several analysts recently weighed in on the company. Evercore ISI decreased their target price on Sherwin-Williams from $410.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. StockNews.com cut shares of Sherwin-Williams from a “buy” rating to a “hold” rating in a research note on Wednesday. UBS Group restated an “underperform” rating on shares of Sherwin-Williams in a research report on Friday, October 18th. Morgan Stanley upped their price objective on shares of Sherwin-Williams from $375.00 to $450.00 and gave the company an “overweight” rating in a research report on Friday, October 18th. Finally, BMO Capital Markets boosted their price target on Sherwin-Williams from $400.00 to $425.00 and gave the company an “outperform” rating in a research note on Monday, September 30th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Sherwin-Williams has a consensus rating of “Moderate Buy” and a consensus target price of $395.29.
Check Out Our Latest Stock Report on SHW
Sherwin-Williams Profile
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Featured Stories
- Five stocks we like better than Sherwin-Williams
- Dividend Payout Ratio Calculator
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 ETFs With Low Fees and Market-Beating Returns
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.